Edition:
United States

BioLife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

5.29USD
23 Feb 2018
Change (% chg)

$0.03 (+0.57%)
Prev Close
$5.26
Open
$5.26
Day's High
$5.29
Day's Low
$5.25
Volume
2,212
Avg. Vol
25,301
52-wk High
$7.53
52-wk Low
$1.93

Select another date:

Tue, Feb 13 2018

BRIEF-Biolife Solutions Executes OEM Agreement With MilliporeSigma

* BIOLIFE SOLUTIONS EXECUTES OEM AGREEMENT WITH MILLIPORESIGMA Source text for Eikon: Further company coverage:

BRIEF-Biolife Solutions Says Co And Savsu Technologies Amended Their Arrangement With Respect To JV

* BIOLIFE SOLUTIONS SAYS ON JAN 22 CO AND SAVSU TECHNOLOGIES AMENDED THEIR ARRANGEMENT WITH RESPECT TO THEIR JV, BIOLOGISTEX- SEC FILING

BRIEF-Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics

* BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS

BRIEF-Biolife Solutions Executes Additional Long-Term Supply Agreement With Leading T Cell Therapy Customer

* BIOLIFE SOLUTIONS EXECUTES ADDITIONAL LONG-TERM SUPPLY AGREEMENT WITH LEADING T CELL THERAPY CUSTOMER Source text for Eikon: Further company coverage:

BRIEF-BioLife Solutions posts Q3 loss per share $0.03

* Biolife Solutions announces third quarter 2017 financial results

BRIEF-Biolife Solutions to report Q3 results and provide business update on Nov 9

* Biolife Solutions to report third quarter 2017 financial results and provide business update on November 9, 2017 Source text for Eikon: Further company coverage:

BRIEF-BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin

* BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin Source text for Eikon: Further company coverage:

Select another date: